UGER ROBERT (Chief Scientific Officer) sold 2.92K shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $34.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/15/2021ACC: 0001062993-21-002721
Officer· Chief Scientific Officer
Since Jan 2021
-2.92K
Net shares
Net seller
$34.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.92K acquired · 5.83K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+2.92K
Price / share
$3.39
Trade value
$9.90K
% of position
New position
3/12/2021
0.00→2.92K
Common Shares
Direct
Shares
−2.92K
Price / share
$11.97
Trade value
$34.92K
% of position
New position
3/12/2021
2.92K→0.00
Total
Net shares
+0.00
Net value
-$25.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/12/2021 | M · Option Exercise | +2.92K | $3.39 | $9.90K | New position | 0.00 | 2.92K |
| Common Shares Direct | 3/12/2021 | S · Sale | −2.92K | $11.97 | $34.92K | New position | 2.92K | 0.00 |
| Total | +0.00 | -$25.02K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
2.92K shares
Shares
−2.92K
Strike price
3.3924
Held after
58.33K
Exercisable
—
3/12/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares2.92K shares | 3/12/2021 | M · Option Exercise | −2.92K | 3.3924 | — | 58.33K |